{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-004285","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2024-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.295695+00:00","generated_at":"2026-06-04T06:03:43.916552+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nutex Health reports Q4 net loss of $31.6M on $69.7M revenue; FY 2023 revenue up 13%","bullets":["Q4 revenue $69.7M (+30% YoY); net loss $31.6M including $29.1M non-cash asset impairment.","FY 2023 revenue $247.6M (+13% YoY); net loss $45.8M vs $424.8M in 2022.","Adjusted EBITDA Q4 $3.1M (vs -$5.9M); FY $10.8M (vs $12.6M).","Hospital division operating income $36.3M (+142%); net cash from operating activities $1.3M.","Management initiated 2024 strategic plan for cost reduction and portfolio optimization."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-004285","json":"https://secwatch.observer/filing/0001558370-24-004285.json","markdown":"https://secwatch.observer/filing/0001558370-24-004285.md","text":"https://secwatch.observer/filing/0001558370-24-004285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/0001558370-24-004285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/nutx-20240328x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T06:03:43.916552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c1ec8f7be5ee50d07e3b76caf3a987b3871277fb","claim":"Nutex Health Inc. reported financial results for the quarter ending December 31, 2023.","evidence_excerpt":"On March 28, 2024, Nutex Health Inc. (the “Company”) announced its financial and operating results for the quarter ending December 31, 2023. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/0001558370-24-004285-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ending December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"d919c1d6e2c425a104a7c9da28fbfa90722b422f","claim":"Nutex Health Inc. reported financial results for the year ended December 31, 2023.","evidence_excerpt":"On March 28, 2024, Nutex Health Inc. (the “Company”) announced its financial and operating results for the quarter ending December 31, 2023. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/0001558370-24-004285-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}